ADH1B promotes mesothelial clearance and ovarian cancer infiltration

Primary debulking surgery followed by adjuvant chemotherapy is the standard treatment for ovarian cancer. Residual disease after primary surgery is associated with poor patient outcome. Previously, we discovered ADH1B to be a molecular biomarker of residual disease. In the current study, we investig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Gharpure, Kshipra M., Lara, Olivia D., Wen, Yunfei, Pradeep, Sunila, LaFargue, Chris, Ivan, Cristina, Rupaimoole, Rajesha, Hu, Wei, Mangala, Lingegowda S., Wu, Sherry Y., Nagaraja, Archana S., Baggerly, Keith, Sood, Anil K.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5982754/
https://ncbi.nlm.nih.gov/pubmed/29861857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25344
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados